Tirzepatide Providers in Washington
1 provider offering Tirzepatide in Washington
About Tirzepatide
Tirzepatide is a dual GIP/GLP-1 receptor agonist marketed as Mounjaro (for diabetes) and Zepbound (for weight loss). It is the first medication to activate both incretin hormone receptors simultaneously, leading to superior weight loss results compared to GLP-1-only medications. Clinical trials showed average weight loss of up to 22.5% of body weight.
Learn more about TirzepatideA
Comparing care options here? For cost-specific research, see Tirzepatide pricing in Washington.
Medical Disclaimer: This content is for informational purposes only and should not be considered medical advice. Always consult with a qualified healthcare provider before beginning any peptide therapy treatment.